TrialAntimicrobial agents and chemotherapy2021

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I Study.

Yinjuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.